| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.872 | 0.004 | 0.872 | Aldehyde oxidase inhibitor | 0.305 0.065 CID_22473 0.241 0.086 CID_124202060 0.444 0.041 CID_3083879 | ||
| 0.801 | 0.003 | 0.801 | Alcohol oxidase inhibitor | 0.122 0.014 CID_124202060 0.085 0.022 CID_3083879 | ||
| 0.761 | 0.016 | 0.761 | Caspase 9 stimulant | 0.29 0.204 CID_22473 0.761 0.016 CID_124202060 0.269 0.23 CID_3083879 | ||
| 0.738 | 0.005 | 0.814 | Free radical scavenger | 0.248 0.069 CID_22473 0.814 0.004 CID_124202060 0.47 0.019 CID_3083879 | CID_124202060 | |
| 0.73 | 0.003 | 0.73 | Peroxidase inhibitor | 0.354 0.028 CID_22473 0.214 0.055 CID_124202060 0.576 0.005 CID_3083879 | ||
| 0.703 | 0.005 | 0.863 | Antioxidant | 0.561 0.014 CID_22473 0.863 0.004 CID_124202060 0.732 0.005 CID_3083879 | CID_124202060 | |
| 0.69 | 0.004 | 0.764 | Superoxide dismutase inhibitor | 0.749 0.004 CID_22473 0.216 0.101 CID_124202060 0.764 0.003 CID_3083879 | CID_3083879 | |
| 0.687 | 0.008 | 0.687 | 5 Hydroxytryptamine release stimulant | 0.242 0.093 CID_22473 0.541 0.021 CID_124202060 0.19 0.13 CID_3083879 | ||
| 0.679 | 0.005 | 0.679 | Amyloid beta aggregation inhibitor | 0.373 0.029 CID_124202060 0.197 0.079 CID_3083879 | ||
| 0.667 | 0.004 | 0.667 | GABA C receptor rho-3 antagonist | 0.222 0.182 CID_22473 0.383 0.069 CID_3083879 | ||
| 0.655 | 0.003 | 0.655 | Tyrosine 3 hydroxylase inhibitor | 0.24 0.079 CID_22473 0.205 0.127 CID_124202060 0.332 0.021 CID_3083879 | ||
| 0.61 | 0.004 | 0.733 | Alpha-N-acetylglucosaminidase inhibitor | 0.113 0.085 CID_22473 0.733 0.003 CID_124202060 0.205 0.033 CID_3083879 | CID_124202060 | |
| 0.584 | 0.013 | 0.66 | 5 Hydroxytryptamine release inhibitor | 0.259 0.215 CID_22473 0.66 0.005 CID_124202060 0.243 0.238 CID_3083879 | CID_124202060 | |
| 0.615 | 0.046 | 0.744 | Apoptosis agonist | 0.262 0.202 CID_22473 0.744 0.024 CID_124202060 0.307 0.167 CID_3083879 | CID_124202060 | |
| 0.58 | 0.012 | 0.785 | Histamine release inhibitor | 0.46 0.045 CID_22473 0.785 0.004 CID_124202060 0.528 0.021 CID_3083879 | CID_124202060 | |
| 0.565 | 0.003 | 0.565 | 5 Hydroxytryptamine uptake stimulant | 0.267 0.066 CID_22473 0.232 0.1 CID_124202060 0.308 0.041 CID_3083879 | ||
| 0.574 | 0.022 | 0.725 | Cholesterol antagonist | 0.614 0.017 CID_22473 0.725 0.006 CID_124202060 0.664 0.011 CID_3083879 | CID_124202060 | |
| 0.544 | 0.003 | 0.544 | GABA C receptor agonist | 0.122 0.048 CID_124202060 0.168 0.028 CID_3083879 | ||
| 0.542 | 0.003 | 0.542 | Porphobilinogen synthase inhibitor | 0.076 0.05 CID_22473 0.249 0.008 CID_3083879 | ||
| 0.519 | 0.004 | 0.519 | Chelator | 0.133 0.044 CID_124202060 | ||
| 0.521 | 0.02 | 0.521 | Calcium channel L-type activator | |||
| 0.517 | 0.018 | 0.517 | Caspase 3 stimulant | 0.441 0.032 CID_124202060 | ||
| 0.502 | 0.005 | 0.515 | Lipid peroxidase inhibitor | 0.17 0.055 CID_22473 0.515 0.005 CID_124202060 0.33 0.015 CID_3083879 | CID_124202060 | |
| 0.558 | 0.065 | 0.873 | Antiinflammatory | 0.352 0.171 CID_22473 0.873 0.007 CID_124202060 0.57 0.062 CID_3083879 | CID_124202060 | |
| 0.493 | 0.004 | 0.493 | Cystathionine beta-synthase inhibitor | 0.097 0.08 CID_22473 0.434 0.004 CID_124202060 0.172 0.032 CID_3083879 | ||
| 0.504 | 0.032 | 0.504 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.471 | 0.003 | 0.471 | M18 aspartyl aminopeptidase inhibitor | 0.099 0.093 CID_124202060 0.126 0.066 CID_3083879 | ||
| 0.466 | 0.002 | 0.466 | Creatine kinase inhibitor | 0.117 0.043 CID_22473 0.153 0.023 CID_124202060 0.288 0.004 CID_3083879 | ||
| 0.466 | 0.004 | 0.741 | HIV-1 integrase (3'-Processing) inhibitor | 0.504 0.003 CID_22473 0.133 0.016 CID_124202060 0.741 0.002 CID_3083879 | CID_3083879 | |
| 0.465 | 0.003 | 0.465 | Succinate dehydrogenase inhibitor | 0.271 0.016 CID_22473 0.211 0.04 CID_124202060 0.302 0.01 CID_3083879 | ||
| 0.46 | 0.003 | 0.46 | Phenylalanine 4-hydroxylase inhibitor | 0.095 0.028 CID_124202060 0.226 0.005 CID_3083879 | ||
| 0.479 | 0.033 | 0.497 | Vasodilator, peripheral | 0.497 0.028 CID_124202060 | CID_124202060 | |
| 0.487 | 0.043 | 0.487 | 15-Lipoxygenase inhibitor | 0.333 0.11 CID_22473 0.432 0.061 CID_3083879 | ||
| 0.445 | 0.005 | 0.445 | 5-Lipoxygenase inhibitor | |||
| 0.44 | 0.012 | 0.465 | Anesthetic general | 0.465 0.01 CID_124202060 | CID_124202060 | |
| 0.453 | 0.027 | 0.453 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.45 | 0.028 | 0.636 | Apoptosis antagonist | 0.636 0.006 CID_124202060 | CID_124202060 | |
| 0.429 | 0.007 | 0.515 | NOS3 expression enhancer | 0.515 0.005 CID_124202060 0.147 0.075 CID_3083879 | CID_124202060 | |
| 0.449 | 0.029 | 0.449 | 12-Lipoxygenase inhibitor | 0.186 0.167 CID_3083879 | ||
| 0.428 | 0.016 | 0.428 | Calcium channel activator | 0.359 0.044 CID_22473 0.274 0.12 CID_3083879 | ||
| 0.422 | 0.016 | 0.505 | RNA-directed DNA polymerase inhibitor | 0.444 0.014 CID_22473 0.365 0.022 CID_124202060 0.505 0.01 CID_3083879 | CID_3083879 | |
| 0.404 | 0.005 | 0.504 | UDP-glucose 4-epimerase inhibitor | 0.504 0.003 CID_124202060 0.132 0.036 CID_3083879 | CID_124202060 | |
| 0.403 | 0.009 | 0.771 | Amylase inhibitor | 0.771 0.002 CID_124202060 | CID_124202060 | |
| 0.446 | 0.054 | 0.811 | Transcription factor NF kappa B inhibitor | 0.265 0.116 CID_22473 0.811 0.012 CID_124202060 0.302 0.093 CID_3083879 | CID_124202060 | |
| 0.401 | 0.01 | 0.401 | Mcl-1 antagonist | |||
| 0.394 | 0.004 | 0.394 | Histidine decarboxylase inhibitor | 0.077 0.045 CID_124202060 0.067 0.053 CID_3083879 | ||
| 0.392 | 0.005 | 0.392 | Interleukin 4 antagonist | 0.229 0.016 CID_124202060 | ||
| 0.387 | 0.004 | 0.387 | Estrogen receptor beta antagonist | 0.118 0.034 CID_3083879 | ||
| 0.389 | 0.006 | 0.48 | Neurotrophic factor enhancer | 0.48 0.004 CID_124202060 0.165 0.117 CID_3083879 | CID_124202060 | |
| 0.401 | 0.02 | 0.401 | Pyruvate kinase inhibitor | 0.136 0.129 CID_3083879 | ||
| 0.39 | 0.009 | 0.39 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.346 0.013 CID_124202060 0.164 0.119 CID_3083879 | ||
| 0.394 | 0.015 | 0.645 | Dual specificity phosphatase inhibitor | 0.563 0.005 CID_22473 0.645 0.004 CID_3083879 | CID_3083879 | |
| 0.383 | 0.005 | 0.383 | Estrogen antagonist | 0.115 0.065 CID_124202060 0.12 0.055 CID_3083879 | ||
| 0.381 | 0.004 | 0.627 | HIV-1 integrase (Strand Transfer) inhibitor | 0.463 0.003 CID_22473 0.115 0.018 CID_124202060 0.627 0.002 CID_3083879 | CID_3083879 | |
| 0.391 | 0.015 | 0.652 | Dual specificity phosphatase 3 inhibitor | 0.572 0.005 CID_22473 0.652 0.004 CID_3083879 | CID_3083879 | |
| 0.382 | 0.012 | 0.47 | Phospholipase C inhibitor | 0.26 0.023 CID_22473 0.248 0.025 CID_124202060 0.47 0.007 CID_3083879 | CID_3083879 | |
| 0.395 | 0.028 | 0.783 | Hypoglycemic | 0.783 0.004 CID_124202060 | CID_124202060 | |
| 0.382 | 0.022 | 0.507 | Interleukin agonist | 0.507 0.008 CID_124202060 | CID_124202060 | |
| 0.363 | 0.004 | 0.374 | Nitric-oxide synthase stimulant | 0.18 0.129 CID_22473 0.374 0.004 CID_124202060 0.198 0.093 CID_3083879 | CID_124202060 | |
| 0.38 | 0.024 | 0.38 | Sodium/bile acid cotransporter inhibitor | 0.307 0.073 CID_22473 0.233 0.147 CID_124202060 0.334 0.051 CID_3083879 | ||
| 0.393 | 0.037 | 0.597 | Vasodilator, coronary | 0.203 0.18 CID_22473 0.597 0.008 CID_124202060 | CID_124202060 | |
| 0.393 | 0.039 | 0.393 | Lipoxygenase inhibitor | |||
| 0.401 | 0.047 | 0.401 | Streptokinase A inhibitor | |||
| 0.364 | 0.014 | 0.364 | Tubulin antagonist | 0.338 0.015 CID_22473 0.184 0.042 CID_3083879 | ||
| 0.384 | 0.035 | 0.41 | Hypoxia-inducible factor 1 alpha inhibitor | 0.181 0.177 CID_22473 0.41 0.028 CID_124202060 0.202 0.149 CID_3083879 | CID_124202060 | |
| 0.352 | 0.004 | 0.595 | Triose-phosphate isomerase inhibitor | 0.441 0.003 CID_22473 0.51 0.002 CID_124202060 0.595 0.002 CID_3083879 | CID_3083879 | |
| 0.369 | 0.029 | 0.637 | Nitric oxide antagonist | 0.146 0.099 CID_22473 0.637 0.008 CID_124202060 0.204 0.066 CID_3083879 | CID_124202060 | |
| 0.344 | 0.004 | 0.344 | Carbonic anhydrase III inhibitor | 0.208 0.015 CID_22473 0.236 0.011 CID_124202060 0.296 0.005 CID_3083879 | ||
| 0.342 | 0.005 | 0.342 | Ferrochelatase inhibitor | |||
| 0.365 | 0.029 | 0.365 | Insulysin inhibitor | 0.228 0.119 CID_3083879 | ||
| 0.347 | 0.016 | 0.551 | Melanin inhibitor | 0.551 0.005 CID_124202060 0.134 0.108 CID_3083879 | CID_124202060 | |
| 0.331 | 0.004 | 0.331 | Mannose-6-phosphate isomerase inhibitor | 0.327 0.004 CID_124202060 0.131 0.084 CID_3083879 | ||
| 0.429 | 0.103 | 0.769 | Alpha-glucosidase inhibitor | 0.769 0.022 CID_124202060 0.273 0.174 CID_3083879 | CID_124202060 | |
| 0.35 | 0.026 | 0.574 | Cyclic AMP phosphodiesterase inhibitor | 0.574 0.004 CID_124202060 | CID_124202060 | |
| 0.326 | 0.003 | 0.326 | Glutamate decarboxylase inhibitor | 0.08 0.044 CID_22473 0.095 0.033 CID_124202060 0.171 0.01 CID_3083879 | ||
| 0.326 | 0.006 | 0.326 | Carbonic anhydrase XV inhibitor | 0.17 0.025 CID_22473 0.223 0.015 CID_3083879 | ||
| 0.322 | 0.006 | 0.5 | NADH dehydrogenase inhibitor | 0.123 0.027 CID_22473 0.5 0.003 CID_124202060 0.173 0.013 CID_3083879 | CID_124202060 | |
| 0.35 | 0.034 | 0.35 | Transcription factor STAT inhibitor | |||
| 0.392 | 0.08 | 0.7 | Antibacterial | 0.452 0.056 CID_22473 0.7 0.009 CID_124202060 0.541 0.03 CID_3083879 | CID_124202060 | |
| 0.314 | 0.005 | 0.348 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.348 0.005 CID_124202060 0.082 0.078 CID_3083879 | CID_124202060 | |
| 0.344 | 0.035 | 0.517 | Vasodilator | 0.517 0.011 CID_124202060 | CID_124202060 | |
| 0.314 | 0.005 | 0.314 | GABA C receptor rho-2 antagonist | 0.139 0.089 CID_22473 0.13 0.105 CID_3083879 | ||
| 0.316 | 0.01 | 0.327 | NADPH oxidase inhibitor | 0.327 0.009 CID_124202060 | CID_124202060 | |
| 0.305 | 0.004 | 0.305 | GABA C receptor antagonist | 0.156 0.027 CID_22473 0.207 0.011 CID_3083879 | ||
| 0.338 | 0.037 | 0.338 | Transcription factor STAT3 inhibitor | |||
| 0.332 | 0.034 | 0.488 | DNA synthesis inhibitor | 0.184 0.148 CID_22473 0.488 0.014 CID_124202060 0.218 0.097 CID_3083879 | CID_124202060 | |
| 0.345 | 0.049 | 0.345 | Aryl hydrocarbon receptor agonist | |||
| 0.298 | 0.005 | 0.535 | Estrogen agonist | 0.319 0.005 CID_22473 0.121 0.014 CID_124202060 0.535 0.003 CID_3083879 | CID_3083879 | |
| 0.331 | 0.038 | 0.869 | Angiogenesis stimulant | 0.649 0.005 CID_22473 0.869 0.003 CID_124202060 0.77 0.004 CID_3083879 | CID_124202060 | |
| 0.308 | 0.017 | 0.408 | Topoisomerase II inhibitor | 0.408 0.01 CID_124202060 0.119 0.068 CID_3083879 | CID_124202060 | |
| 0.308 | 0.022 | 0.482 | Peptidyltransferase inhibitor | 0.482 0.004 CID_124202060 | CID_124202060 | |
| 0.298 | 0.012 | 0.298 | Aldehyde dehydrogenase inhibitor | 0.289 0.013 CID_124202060 | ||
| 0.292 | 0.006 | 0.292 | Carbonic anhydrase VI inhibitor | 0.168 0.017 CID_22473 0.159 0.019 CID_124202060 0.247 0.009 CID_3083879 | ||
| 0.288 | 0.004 | 0.288 | HIV-1 integrase (Overall Integration) inhibitor | 0.115 0.043 CID_22473 0.213 0.009 CID_3083879 | ||
| 0.301 | 0.019 | 0.6 | Protein-tyrosine phosphatase inhibitor | 0.48 0.005 CID_22473 0.216 0.041 CID_124202060 0.6 0.004 CID_3083879 | CID_3083879 | |
| 0.302 | 0.02 | 0.498 | Interferon gamma antagonist | 0.498 0.006 CID_124202060 0.126 0.12 CID_3083879 | CID_124202060 | |
| 0.286 | 0.004 | 0.286 | Alpha tubulin antagonist | |||
| 0.338 | 0.056 | 0.517 | Spasmolytic | 0.202 0.118 CID_22473 0.517 0.021 CID_124202060 0.23 0.1 CID_3083879 | CID_124202060 | |
| 0.325 | 0.048 | 0.352 | DNA damaging | 0.352 0.04 CID_124202060 | CID_124202060 | |
| 0.279 | 0.003 | 0.279 | DOPA decarboxylase inhibitor | 0.111 0.057 CID_124202060 0.144 0.025 CID_3083879 | ||
| 0.301 | 0.026 | 0.502 | DNA methyltransferase I inhibitor | 0.502 0.005 CID_124202060 | CID_124202060 | |
| 0.302 | 0.028 | 0.302 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.281 | 0.008 | 0.281 | Adenylate kinase inhibitor | 0.115 0.048 CID_22473 0.181 0.018 CID_124202060 0.164 0.022 CID_3083879 | ||
| 0.277 | 0.005 | 0.277 | Dopamine agonist | 0.08 0.037 CID_22473 0.226 0.008 CID_3083879 | ||
| 0.338 | 0.069 | 0.759 | Antithrombotic | 0.455 0.037 CID_22473 0.759 0.005 CID_124202060 0.513 0.027 CID_3083879 | CID_124202060 | |
| 0.289 | 0.019 | 0.663 | Monophenol monooxygenase inhibitor | 0.14 0.051 CID_22473 0.663 0.004 CID_124202060 0.209 0.031 CID_3083879 | CID_124202060 | |
| 0.274 | 0.005 | 0.274 | Beta tubulin antagonist | |||
| 0.314 | 0.046 | 0.314 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.374 | 0.106 | 0.87 | Cyclophilin D inhibitor | 0.237 0.228 CID_22473 0.87 0.005 CID_124202060 0.442 0.07 CID_3083879 | CID_124202060 | |
| 0.296 | 0.031 | 0.664 | Hepatoprotectant | 0.277 0.036 CID_22473 0.664 0.004 CID_124202060 0.325 0.023 CID_3083879 | CID_124202060 | |
| 0.278 | 0.013 | 0.278 | DNA polymerase I inhibitor | 0.234 0.02 CID_124202060 0.101 0.085 CID_3083879 | ||
| 0.27 | 0.005 | 0.27 | Vanilloid agonist | 0.098 0.035 CID_22473 0.089 0.048 CID_124202060 0.129 0.015 CID_3083879 | ||
| 0.269 | 0.005 | 0.269 | Keratolytic | 0.077 0.053 CID_124202060 0.073 0.059 CID_3083879 | ||
| 0.293 | 0.03 | 0.513 | DNA methylase inhibitor | 0.513 0.005 CID_124202060 | CID_124202060 | |
| 0.27 | 0.009 | 0.27 | 5 Hydroxytryptamine 3E antagonist | 0.171 0.132 CID_22473 0.178 0.111 CID_3083879 | ||
| 0.294 | 0.036 | 0.526 | Platelet adhesion inhibitor | 0.473 0.006 CID_22473 0.526 0.005 CID_124202060 0.508 0.005 CID_3083879 | CID_124202060 | |
| 0.307 | 0.049 | 0.456 | Antiamyloidogenic | 0.456 0.02 CID_124202060 | CID_124202060 | |
| 0.258 | 0.004 | 0.258 | Adenylate cyclase stimulant | 0.196 0.015 CID_22473 0.192 0.018 CID_124202060 0.246 0.004 CID_3083879 | ||
| 0.256 | 0.005 | 0.256 | Macrophage migration inhibitory factor inhibitor | 0.089 0.042 CID_3083879 | ||
| 0.272 | 0.021 | 0.471 | Protein kinase stimulant | 0.471 0.005 CID_124202060 | CID_124202060 | |
| 0.255 | 0.004 | 0.255 | Prolactin inhibitor | 0.097 0.058 CID_3083879 | ||
| 0.272 | 0.025 | 0.272 | Amyloid beta precursor protein antagonist | |||
| 0.258 | 0.012 | 0.258 | Death-associated protein kinase 2 inhibitor | |||
| 0.258 | 0.012 | 0.409 | ATPase inhibitor | 0.409 0.004 CID_124202060 | CID_124202060 | |
| 0.288 | 0.042 | 0.288 | Gastrin inhibitor | 0.206 0.139 CID_124202060 | ||
| 0.25 | 0.004 | 0.295 | HIV-1 integrase inhibitor | 0.155 0.008 CID_22473 0.084 0.035 CID_124202060 0.295 0.004 CID_3083879 | CID_3083879 | |
| 0.254 | 0.009 | 0.254 | Toll-Like receptor 2 antagonist | 0.146 0.056 CID_124202060 | ||
| 0.333 | 0.089 | 0.333 | Prostaglandin dehydrogenase inhibitor | |||
| 0.304 | 0.061 | 0.304 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.288 | 0.047 | 0.456 | Antimitotic | 0.456 0.016 CID_22473 0.322 0.039 CID_3083879 | CID_22473 | |
| 0.245 | 0.004 | 0.245 | GABA C receptor rho-1 antagonist | |||
| 0.246 | 0.006 | 0.246 | Arachidonic acid antagonist | 0.178 0.056 CID_22473 0.196 0.036 CID_124202060 0.204 0.029 CID_3083879 | ||
| 0.285 | 0.047 | 0.285 | Psychostimulant | 0.282 0.048 CID_124202060 | ||
| 0.287 | 0.051 | 0.287 | Interleukin antagonist | |||
| 0.252 | 0.017 | 0.316 | Cholesterol synthesis inhibitor | 0.292 0.012 CID_22473 0.172 0.035 CID_124202060 0.316 0.01 CID_3083879 | CID_3083879 | |
| 0.242 | 0.008 | 0.242 | CF transmembrane conductance regulator agonist | 0.173 0.043 CID_124202060 | ||
| 0.304 | 0.071 | 0.493 | Interleukin 2 agonist | 0.493 0.009 CID_124202060 | CID_124202060 | |
| 0.252 | 0.019 | 0.252 | Adenylate cyclase inhibitor | 0.161 0.038 CID_124202060 | ||
| 0.24 | 0.008 | 0.361 | Phosphofructokinase-1 inhibitor | 0.071 0.047 CID_22473 0.361 0.004 CID_124202060 0.142 0.02 CID_3083879 | CID_124202060 | |
| 0.238 | 0.008 | 0.238 | Uric acid excretion stimulant | 0.23 0.009 CID_124202060 | ||
| 0.242 | 0.014 | 0.678 | Expectorant | 0.117 0.053 CID_22473 0.678 0.002 CID_124202060 0.113 0.056 CID_3083879 | CID_124202060 | |
| 0.253 | 0.025 | 0.253 | Heat shock protein 90 alpha antagonist | |||
| 0.284 | 0.058 | 0.284 | Dyrk kinase inhibitor | |||
| 0.236 | 0.011 | 0.303 | Topoisomerase II alpha inhibitor | 0.303 0.007 CID_124202060 | CID_124202060 | |
| 0.249 | 0.026 | 0.249 | Histone acetyltransferase inhibitor | |||
| 0.242 | 0.019 | 0.385 | Hexokinase inhibitor | 0.385 0.005 CID_124202060 | CID_124202060 | |
| 0.254 | 0.032 | 0.254 | Insulin sensitizer | 0.227 0.049 CID_124202060 0.159 0.121 CID_3083879 | ||
| 0.231 | 0.008 | 0.281 | Mucolytic | 0.139 0.039 CID_22473 0.281 0.005 CID_124202060 0.136 0.041 CID_3083879 | CID_124202060 | |
| 0.261 | 0.039 | 0.577 | Non-steroidal antiinflammatory agent | 0.195 0.075 CID_22473 0.577 0.005 CID_124202060 0.178 0.089 CID_3083879 | CID_124202060 | |
| 0.224 | 0.002 | 0.224 | Dopamine D5 agonist | 0.072 0.008 CID_3083879 | ||
| 0.24 | 0.018 | 0.356 | Topoisomerase I inhibitor | 0.356 0.007 CID_124202060 0.105 0.066 CID_3083879 | CID_124202060 | |
| 0.232 | 0.01 | 0.687 | Carbonic anhydrase XIII inhibitor | 0.622 0.003 CID_22473 0.328 0.005 CID_124202060 0.687 0.003 CID_3083879 | CID_3083879 | |
| 0.229 | 0.009 | 0.229 | Alcohol dehydrogenase inhibitor | 0.197 0.013 CID_124202060 0.085 0.071 CID_3083879 | ||
| 0.313 | 0.095 | 0.313 | Thioredoxin glutathione reductase inhibitor | |||
| 0.28 | 0.061 | 0.705 | Tumour necrosis factor alpha release inhibitor | 0.167 0.137 CID_22473 0.705 0.005 CID_124202060 | CID_124202060 | |
| 0.241 | 0.023 | 0.241 | Cyclooxygenase 1 inhibitor | 0.144 0.06 CID_22473 0.117 0.083 CID_124202060 0.192 0.038 CID_3083879 | ||
| 0.239 | 0.022 | 0.317 | Alkaline phosphatase inhibitor | 0.268 0.017 CID_22473 0.256 0.019 CID_124202060 0.317 0.01 CID_3083879 | CID_3083879 | |
| 0.24 | 0.024 | 0.24 | Heat shock protein 90 antagonist | |||
| 0.224 | 0.009 | 0.224 | 5 Hydroxytryptamine 3A agonist | |||
| 0.216 | 0.002 | 0.216 | Catechol O-methyltransferase inhibitor | 0.129 0.004 CID_3083879 | ||
| 0.231 | 0.02 | 0.419 | Cell wall synthesis inhibitor | 0.31 0.009 CID_22473 0.413 0.005 CID_124202060 0.419 0.005 CID_3083879 | CID_3083879 | |
| 0.231 | 0.021 | 0.409 | Protein-tyrosine phosphatase 1B inhibitor | 0.281 0.012 CID_22473 0.209 0.027 CID_124202060 0.409 0.005 CID_3083879 | CID_3083879 | |
| 0.242 | 0.031 | 0.242 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.213 | 0.005 | 0.229 | Heat shock protein 70 antagonist | 0.229 0.004 CID_124202060 | CID_124202060 | |
| 0.221 | 0.013 | 0.567 | Cyclooxygenase 3 inhibitor | 0.567 0.003 CID_124202060 | CID_124202060 | |
| 0.212 | 0.004 | 0.212 | Estrogen receptor alpha agonist | |||
| 0.223 | 0.016 | 0.223 | Farnesoid X receptor antagonist | |||
| 0.212 | 0.005 | 0.352 | CDC25A inhibitor | 0.239 0.005 CID_22473 0.352 0.003 CID_3083879 | CID_3083879 | |
| 0.212 | 0.004 | 0.317 | Estrogen receptor beta agonist | 0.133 0.008 CID_22473 0.076 0.015 CID_124202060 0.317 0.004 CID_3083879 | CID_3083879 | |
| 0.222 | 0.016 | 0.425 | Xanthine oxidase inhibitor | 0.425 0.004 CID_124202060 | CID_124202060 | |
| 0.214 | 0.009 | 0.214 | Glutamate dehydrogenase inhibitor | 0.065 0.064 CID_22473 0.128 0.02 CID_124202060 0.113 0.025 CID_3083879 | ||
| 0.286 | 0.083 | 0.555 | Immunostimulant | 0.298 0.079 CID_22473 0.555 0.022 CID_124202060 0.38 0.056 CID_3083879 | CID_124202060 | |
| 0.204 | 0.003 | 0.204 | D-Ala-D-Ala ligase inhibitor | 0.099 0.03 CID_3083879 | ||
| 0.211 | 0.012 | 0.681 | Beta glucuronidase inhibitor | 0.681 0.002 CID_124202060 | CID_124202060 | |
| 0.211 | 0.012 | 0.211 | Potassium channel (Ca-activated) activator | |||
| 0.251 | 0.053 | 0.251 | MAP kinase kinase 2 inhibitor | |||
| 0.207 | 0.009 | 0.207 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.078 0.053 CID_22473 0.098 0.038 CID_3083879 | ||
| 0.201 | 0.003 | 0.201 | Ca2+-transporting ATPase inhibitor | 0.137 0.084 CID_22473 0.191 0.004 CID_124202060 0.151 0.04 CID_3083879 | ||
| 0.307 | 0.11 | 0.566 | Immunosuppressant | 0.566 0.018 CID_124202060 | CID_124202060 | |
| 0.205 | 0.009 | 0.205 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.222 | 0.027 | 0.222 | Neurotensin receptor agonist | 0.145 0.115 CID_22473 0.14 0.129 CID_3083879 | ||
| 0.225 | 0.029 | 0.279 | Interleukin 6 antagonist | 0.279 0.018 CID_124202060 | CID_124202060 | |
| 0.198 | 0.003 | 0.198 | Granulocyte macrophage colony stimulating factor agonist | 0.107 0.026 CID_22473 0.097 0.039 CID_3083879 | ||
| 0.202 | 0.011 | 0.202 | Vanilloid 1 agonist | 0.173 0.021 CID_22473 0.189 0.015 CID_124202060 0.172 0.022 CID_3083879 | ||
| 0.193 | 0.008 | 0.193 | Carbamoyl phosphate synthetase inhibitor | 0.068 0.036 CID_22473 0.095 0.022 CID_124202060 0.112 0.017 CID_3083879 | ||
| 0.196 | 0.011 | 0.196 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.193 | 0.009 | 0.193 | Electrolyte absorption antagonist | |||
| 0.196 | 0.011 | 0.196 | TRPA1 agonist | 0.154 0.029 CID_22473 0.141 0.038 CID_124202060 0.18 0.016 CID_3083879 | ||
| 0.231 | 0.048 | 0.231 | I kappa B kinase epsilon inhibitor | |||
| 0.188 | 0.005 | 0.505 | Dopamine D2 agonist | 0.22 0.005 CID_22473 0.056 0.023 CID_124202060 0.505 0.004 CID_3083879 | CID_3083879 | |
| 0.221 | 0.038 | 0.221 | Cytidine deaminase inhibitor | |||
| 0.196 | 0.014 | 0.267 | Photosensitizer | 0.113 0.067 CID_22473 0.267 0.005 CID_124202060 0.11 0.071 CID_3083879 | CID_124202060 | |
| 0.187 | 0.005 | 0.187 | GABA aminotransferase inhibitor | 0.156 0.007 CID_124202060 | ||
| 0.188 | 0.006 | 0.188 | Biliverdin reductase inhibitor | 0.101 0.018 CID_124202060 | ||
| 0.192 | 0.01 | 0.192 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.11 CID_3083879 | ||
| 0.185 | 0.004 | 0.185 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.052 0.015 CID_3083879 | ||
| 0.202 | 0.021 | 0.235 | Aminopeptidase B inhibitor | 0.177 0.027 CID_22473 0.235 0.015 CID_3083879 | CID_3083879 | |
| 0.194 | 0.014 | 0.194 | Interleukin 8 antagonist | |||
| 0.243 | 0.064 | 0.243 | Neuropeptide Y2 antagonist | |||
| 0.181 | 0.004 | 0.181 | GABA B receptor agonist | 0.085 0.033 CID_22473 0.1 0.017 CID_3083879 | ||
| 0.18 | 0.006 | 0.266 | Carbonic anhydrase VB inhibitor | 0.181 0.006 CID_22473 0.266 0.004 CID_3083879 | CID_3083879 | |
| 0.195 | 0.021 | 0.23 | Microtubule formation inhibitor | 0.108 0.078 CID_22473 0.23 0.014 CID_124202060 0.103 0.086 CID_3083879 | CID_124202060 | |
| 0.324 | 0.15 | 0.324 | DNA directed DNA polymerase inhibitor | |||
| 0.243 | 0.071 | 0.243 | Calpain inhibitor | |||
| 0.188 | 0.018 | 0.221 | Catalase inhibitor | 0.221 0.012 CID_22473 0.218 0.012 CID_3083879 | CID_22473 | |
| 0.191 | 0.02 | 0.191 | Falcipain 3 inhibitor | |||
| 0.187 | 0.017 | 0.187 | Antineoplastic alkaloid | |||
| 0.173 | 0.005 | 0.173 | Purinergic P2X1 antagonist | 0.065 0.037 CID_22473 0.104 0.015 CID_124202060 0.113 0.013 CID_3083879 | ||
| 0.177 | 0.009 | 0.177 | Argininosuccinate synthase inhibitor | 0.093 0.021 CID_124202060 | ||
| 0.173 | 0.006 | 0.173 | Glutamate release inhibitor | 0.17 0.006 CID_124202060 | ||
| 0.17 | 0.005 | 0.17 | Glycine receptor agonist | 0.075 0.045 CID_22473 0.139 0.008 CID_124202060 0.09 0.028 CID_3083879 | ||
| 0.212 | 0.047 | 0.212 | Tumour necrosis factor antagonist | |||
| 0.168 | 0.004 | 0.168 | Aconitate hydratase inhibitor | 0.05 0.038 CID_124202060 0.052 0.036 CID_3083879 | ||
| 0.172 | 0.009 | 0.187 | Aldose reductase inhibitor | 0.094 0.019 CID_22473 0.187 0.008 CID_124202060 0.183 0.008 CID_3083879 | CID_124202060 | |
| 0.173 | 0.01 | 0.512 | Carbonic anhydrase V inhibitor | 0.389 0.003 CID_22473 0.512 0.002 CID_3083879 | CID_3083879 | |
| 0.167 | 0.003 | 0.167 | Estrogen-related receptor beta agonist | 0.081 0.063 CID_22473 0.082 0.062 CID_124202060 0.091 0.039 CID_3083879 | ||
| 0.318 | 0.156 | 0.318 | DNA polymerase beta inhibitor | |||
| 0.166 | 0.004 | 0.166 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.03 CID_22473 0.097 0.011 CID_3083879 | ||
| 0.168 | 0.008 | 0.168 | Myeloperoxidase inhibitor | |||
| 0.167 | 0.008 | 0.167 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.155 0.008 CID_124202060 0.052 0.045 CID_3083879 | ||
| 0.283 | 0.125 | 0.283 | Calpain 2 inhibitor | |||
| 0.165 | 0.008 | 0.165 | Acyl-CoA dehydrogenase inhibitor | 0.068 0.028 CID_124202060 | ||
| 0.169 | 0.013 | 0.169 | Transcription factor STAT6 inhibitor | |||
| 0.205 | 0.05 | 0.465 | Thrombolytic | 0.221 0.043 CID_22473 0.465 0.006 CID_124202060 0.321 0.02 CID_3083879 | CID_124202060 | |
| 0.176 | 0.021 | 0.176 | Pregnane X receptor agonist | 0.128 0.106 CID_22473 0.143 0.066 CID_3083879 | ||
| 0.165 | 0.011 | 0.178 | Anabolic | 0.154 0.016 CID_22473 0.108 0.052 CID_124202060 0.178 0.008 CID_3083879 | CID_3083879 | |
| 0.174 | 0.021 | 0.174 | Protein kinase C gamma inhibitor | |||
| 0.196 | 0.045 | 0.196 | Phospholipase A2 inhibitor | 0.123 0.113 CID_22473 0.156 0.068 CID_124202060 0.148 0.076 CID_3083879 | ||
| 0.193 | 0.043 | 0.193 | MAO inhibitor | |||
| 0.156 | 0.006 | 0.156 | CDC25B inhibitor | |||
| 0.166 | 0.016 | 0.166 | Urease inhibitor | |||
| 0.19 | 0.041 | 0.403 | Insulin secretagoues | 0.403 0.006 CID_124202060 | CID_124202060 | |
| 0.182 | 0.033 | 0.182 | MAO A inhibitor | |||
| 0.177 | 0.03 | 0.177 | Cathepsin H inhibitor | |||
| 0.165 | 0.02 | 0.471 | AMP-activated protein kinase stimulant | 0.471 0.003 CID_124202060 | CID_124202060 | |
| 0.158 | 0.013 | 0.158 | Adrenaline agonist | |||
| 0.164 | 0.019 | 0.164 | Sphingomyelinase inhibitor | 0.089 0.073 CID_22473 0.14 0.029 CID_124202060 | ||
| 0.181 | 0.037 | 0.181 | Anesthetic local | |||
| 0.161 | 0.018 | 0.275 | Protein kinase C zeta inhibitor | 0.198 0.011 CID_22473 0.275 0.006 CID_3083879 | CID_3083879 | |
| 0.153 | 0.01 | 0.334 | Carbonic anhydrase VA inhibitor | 0.266 0.003 CID_22473 0.334 0.003 CID_3083879 | CID_3083879 | |
| 0.164 | 0.021 | 0.309 | DNA repair enzyme inhibitor | 0.309 0.004 CID_124202060 | CID_124202060 | |
| 0.149 | 0.007 | 0.149 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.138 0.009 CID_124202060 | ||
| 0.175 | 0.035 | 0.344 | Alkylator | 0.141 0.051 CID_22473 0.344 0.01 CID_124202060 0.144 0.05 CID_3083879 | CID_124202060 | |
| 0.145 | 0.005 | 0.145 | Topoisomerase II beta inhibitor | 0.111 0.008 CID_124202060 | ||
| 0.172 | 0.032 | 0.172 | Antibacterial (Helicobacter pylori) | 0.136 0.06 CID_22473 0.114 0.09 CID_124202060 0.136 0.06 CID_3083879 | ||
| 0.156 | 0.018 | 0.203 | Toll-Like receptor 4 antagonist | 0.203 0.006 CID_124202060 | CID_124202060 | |
| 0.15 | 0.011 | 0.15 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.179 | 0.043 | 0.521 | Hemostatic | 0.466 0.005 CID_22473 0.492 0.004 CID_124202060 0.521 0.004 CID_3083879 | CID_3083879 | |
| 0.148 | 0.012 | 0.148 | Glutathione S-transferase inhibitor | 0.082 0.057 CID_124202060 | ||
| 0.16 | 0.025 | 0.16 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.147 | 0.012 | 0.147 | Estrogen receptor alpha antagonist | |||
| 0.147 | 0.013 | 0.147 | Aminopeptidase I inhibitor | |||
| 0.145 | 0.012 | 0.145 | Potassium channel large-conductance Ca-activated activator | |||
| 0.182 | 0.049 | 0.182 | Cyclooxygenase inhibitor | |||
| 0.14 | 0.007 | 0.14 | Maillard reaction inhibitor | 0.059 0.035 CID_124202060 | ||
| 0.137 | 0.005 | 0.137 | Plasminogen activator inhibitor antagonist | |||
| 0.182 | 0.051 | 0.182 | Acetylcholine M1 receptor antagonist | |||
| 0.146 | 0.015 | 0.146 | Histamine N-methyltransferase inhibitor | |||
| 0.135 | 0.005 | 0.135 | Heat shock protein 90 beta antagonist | |||
| 0.141 | 0.012 | 0.238 | Phosphodiesterase 6D inhibitor | 0.096 0.06 CID_22473 0.238 0.004 CID_124202060 0.115 0.03 CID_3083879 | CID_124202060 | |
| 0.158 | 0.029 | 0.158 | Bronchodilator | 0.101 0.063 CID_124202060 | ||
| 0.177 | 0.049 | 0.177 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.135 | 0.007 | 0.135 | Dopamine D5 antagonist | |||
| 0.166 | 0.038 | 0.166 | Nav1.6 sodium channel blocker | |||
| 0.134 | 0.007 | 0.134 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.171 | 0.044 | 0.171 | M17 leucyl aminopeptidase inhibitor | |||
| 0.146 | 0.019 | 0.261 | Acetylcholine release stimulant | 0.261 0.004 CID_22473 0.13 0.034 CID_124202060 0.173 0.007 CID_3083879 | CID_22473 | |
| 0.137 | 0.011 | 0.184 | Glycine receptor antagonist | 0.163 0.005 CID_22473 0.184 0.004 CID_124202060 0.182 0.004 CID_3083879 | CID_124202060 | |
| 0.144 | 0.019 | 0.164 | Thioredoxin inhibitor | 0.164 0.013 CID_124202060 | CID_124202060 | |
| 0.192 | 0.069 | 0.2 | P-glycoprotein inhibitor | 0.2 0.064 CID_124202060 | CID_124202060 | |
| 0.127 | 0.004 | 0.127 | Glutamate (mGluR7) antagonist | 0.063 0.057 CID_22473 | ||
| 0.178 | 0.055 | 0.178 | Catenin beta inhibitor | |||
| 0.138 | 0.015 | 0.138 | Ornithine decarboxylase inhibitor | 0.107 0.037 CID_124202060 | ||
| 0.125 | 0.004 | 0.125 | Vanilloid 2 antagonist | 0.064 0.018 CID_22473 0.079 0.01 CID_3083879 | ||
| 0.168 | 0.047 | 0.168 | Bone formation stimulant | 0.116 0.09 CID_124202060 | ||
| 0.149 | 0.029 | 0.149 | Caspase 3 inhibitor | |||
| 0.145 | 0.024 | 0.145 | Androgen antagonist | |||
| 0.185 | 0.065 | 0.185 | Growth hormone agonist | |||
| 0.157 | 0.036 | 0.165 | Beta amyloid protein antagonist | 0.165 0.031 CID_124202060 | CID_124202060 | |
| 0.129 | 0.009 | 0.129 | Xanthine dehydrogenase inhibitor | 0.071 0.03 CID_124202060 | ||
| 0.126 | 0.007 | 0.126 | CC chemokine 5 receptor agonist | 0.085 0.049 CID_22473 0.109 0.014 CID_3083879 | ||
| 0.14 | 0.021 | 0.14 | MAP kinase kinase 1 inhibitor | |||
| 0.147 | 0.03 | 0.429 | Mediator release inhibitor | 0.429 0.005 CID_124202060 | CID_124202060 | |
| 0.175 | 0.057 | 0.499 | Diuretic | 0.36 0.015 CID_22473 0.344 0.017 CID_124202060 0.499 0.008 CID_3083879 | CID_3083879 | |
| 0.121 | 0.004 | 0.121 | MAP kinase kinase 7 inhibitor | |||
| 0.125 | 0.009 | 0.125 | Beta 3 adrenoreceptor antagonist | 0.066 0.041 CID_3083879 | ||
| 0.129 | 0.013 | 0.135 | Bile acid receptor antagonist | 0.115 0.024 CID_22473 0.098 0.054 CID_124202060 0.135 0.011 CID_3083879 | CID_3083879 | |
| 0.145 | 0.029 | 0.17 | CC chemokine 6 receptor antagonist | 0.17 0.008 CID_124202060 | CID_124202060 | |
| 0.118 | 0.004 | 0.155 | Glucose-6-phosphate isomerase inhibitor | 0.056 0.022 CID_22473 0.155 0.002 CID_124202060 0.076 0.01 CID_3083879 | CID_124202060 | |
| 0.159 | 0.046 | 0.159 | MAP kinase kinase 4 inhibitor | |||
| 0.127 | 0.014 | 0.127 | mTOR complex 2 inhibitor | |||
| 0.117 | 0.005 | 0.117 | Sphingosine kinase 2 inhibitor | |||
| 0.127 | 0.015 | 0.149 | ATPase (Vacuolar H+) inhibitor | 0.149 0.008 CID_124202060 | CID_124202060 | |
| 0.115 | 0.003 | 0.115 | Dopamine beta hydroxylase inhibitor | |||
| 0.117 | 0.006 | 0.117 | Glutamate (mGluR6) antagonist | 0.064 0.053 CID_124202060 | ||
| 0.115 | 0.004 | 0.115 | Dihydroorotate oxidase inhibitor | 0.065 0.022 CID_3083879 | ||
| 0.116 | 0.007 | 0.116 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.131 | 0.022 | 0.131 | CYP2A6 inhibitor | |||
| 0.124 | 0.015 | 0.124 | Leukotriene synthesis inhibitor | |||
| 0.127 | 0.018 | 0.127 | Dopamine D1 antagonist | |||
| 0.113 | 0.004 | 0.113 | Squalene epoxidase inhibitor | 0.069 0.014 CID_124202060 | ||
| 0.137 | 0.029 | 0.419 | Breast cancer-resistant protein inhibitor | 0.419 0.005 CID_22473 0.224 0.011 CID_3083879 | CID_22473 | |
| 0.129 | 0.022 | 0.165 | Interleukin 12 antagonist | 0.165 0.009 CID_124202060 | CID_124202060 | |
| 0.145 | 0.039 | 0.145 | MAO B inhibitor | |||
| 0.133 | 0.026 | 0.133 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.163 | 0.059 | 0.163 | Thiol protease inhibitor | |||
| 0.203 | 0.099 | 0.203 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.12 | 0.017 | 0.12 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.127 | 0.024 | 0.127 | Glutamate (mGluR7) agonist | |||
| 0.107 | 0.004 | 0.176 | Adenine nucleotide translocase inhibitor | 0.115 0.004 CID_22473 0.101 0.004 CID_124202060 0.176 0.003 CID_3083879 | CID_3083879 | |
| 0.106 | 0.004 | 0.106 | Alpha 1d adrenoreceptor agonist | |||
| 0.106 | 0.004 | 0.106 | Ryanodine receptor antagonist | 0.057 0.047 CID_22473 | ||
| 0.154 | 0.053 | 0.154 | Toll-Like receptor antagonist | |||
| 0.132 | 0.03 | 0.169 | NMDA receptor antagonist | 0.169 0.019 CID_3083879 | CID_3083879 | |
| 0.106 | 0.005 | 0.146 | Glucose-6-phosphate translocase inhibitor | 0.146 0.003 CID_124202060 | CID_124202060 | |
| 0.148 | 0.048 | 0.148 | Proteasome inhibitor | |||
| 0.234 | 0.134 | 0.234 | Thyroid hormone antagonist | |||
| 0.122 | 0.023 | 0.239 | NMDA 2 receptor antagonist | 0.096 0.034 CID_22473 0.239 0.007 CID_3083879 | CID_3083879 | |
| 0.102 | 0.003 | 0.102 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.045 0.022 CID_22473 0.063 0.006 CID_3083879 | ||
| 0.102 | 0.003 | 0.163 | Dopamine D1 agonist | 0.057 0.004 CID_22473 0.056 0.004 CID_124202060 0.163 0.003 CID_3083879 | CID_3083879 | |
| 0.107 | 0.009 | 0.107 | Fatty acid synthase inhibitor | 0.061 0.035 CID_124202060 | ||
| 0.11 | 0.013 | 0.11 | Beta adrenoreceptor antagonist | |||
| 0.107 | 0.01 | 0.107 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.058 CID_3083879 | ||
| 0.157 | 0.06 | 0.157 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.115 | 0.019 | 0.134 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 CID_22473 0.134 0.01 CID_124202060 0.121 0.016 CID_3083879 | CID_124202060 | |
| 0.109 | 0.013 | 0.109 | NMDA receptor glycine site agonist | |||
| 0.11 | 0.014 | 0.198 | Neuraminidase (influenza) inhibitor | 0.121 0.012 CID_22473 0.171 0.005 CID_124202060 0.198 0.005 CID_3083879 | CID_3083879 | |
| 0.107 | 0.011 | 0.113 | Phospholipase D inhibitor | 0.091 0.021 CID_22473 0.113 0.009 CID_3083879 | CID_3083879 | |
| 0.1 | 0.004 | 0.1 | Adenylate cyclase 1 inhibitor | |||
| 0.141 | 0.047 | 0.141 | Protein kinase (CK2) alpha inhibitor | |||
| 0.104 | 0.01 | 0.104 | NMDA receptor subunit 3B antagonist | |||
| 0.109 | 0.016 | 0.133 | NMDA receptor agonist | 0.085 0.026 CID_22473 0.133 0.01 CID_3083879 | CID_3083879 | |
| 0.101 | 0.009 | 0.101 | CD45 antagonist | |||
| 0.105 | 0.013 | 0.105 | Vanilloid 4 agonist | |||
| 0.133 | 0.041 | 0.133 | Protein kinase (CK2) inhibitor | |||
| 0.099 | 0.008 | 0.119 | Sphingosine kinase inhibitor | 0.071 0.024 CID_22473 0.119 0.005 CID_3083879 | CID_3083879 | |
| 0.112 | 0.021 | 0.112 | Lipase inhibitor | |||
| 0.097 | 0.007 | 0.097 | Transcription factor RelA inhibitor | 0.062 0.048 CID_22473 | ||
| 0.152 | 0.062 | 0.152 | Neuropeptide Y1 antagonist | |||
| 0.1 | 0.011 | 0.174 | Carbonic anhydrase XIV inhibitor | 0.063 0.023 CID_22473 0.174 0.005 CID_124202060 0.074 0.019 CID_3083879 | CID_124202060 | |
| 0.153 | 0.063 | 0.153 | MAP kinase 3 inhibitor | |||
| 0.099 | 0.01 | 0.099 | Exportin-1 inhibitor | |||
| 0.095 | 0.006 | 0.095 | CXC chemokine 1 receptor antagonist | |||
| 0.116 | 0.028 | 0.247 | Cathepsin G inhibitor | 0.218 0.015 CID_22473 0.247 0.013 CID_3083879 | CID_3083879 | |
| 0.127 | 0.038 | 0.169 | Gastric antisecretory | 0.169 0.019 CID_22473 0.155 0.025 CID_3083879 | CID_22473 | |
| 0.135 | 0.047 | 0.135 | Alpha 2b adrenoreceptor antagonist | |||
| 0.115 | 0.028 | 0.115 | Telomerase inhibitor | |||
| 0.093 | 0.006 | 0.093 | Fumarate hydratase inhibitor | 0.051 0.013 CID_124202060 | ||
| 0.264 | 0.177 | 0.264 | Transcription factor inhibitor | |||
| 0.148 | 0.061 | 0.148 | Neurotrophic factor | 0.113 0.108 CID_124202060 | ||
| 0.094 | 0.007 | 0.236 | Alpha-mannosidase inhibitor | 0.098 0.007 CID_22473 0.236 0.003 CID_124202060 0.122 0.005 CID_3083879 | CID_124202060 | |
| 0.1 | 0.014 | 0.1 | Androgen agonist | 0.061 0.04 CID_22473 0.092 0.018 CID_3083879 | ||
| 0.099 | 0.014 | 0.099 | Protein kinase C beta inhibitor | |||
| 0.164 | 0.08 | 0.164 | Antipruritic | |||
| 0.099 | 0.015 | 0.099 | Alpha 2 adrenoreceptor agonist | |||
| 0.112 | 0.028 | 0.112 | Inducible nitric-oxide synthase inhibitor | 0.085 0.054 CID_22473 0.09 0.047 CID_3083879 | ||
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | |||
| 0.106 | 0.024 | 0.153 | Histone deacetylase stimulant | 0.153 0.009 CID_124202060 | CID_124202060 | |
| 0.106 | 0.024 | 0.153 | Histone deacetylase SIRT1 stimulant | 0.153 0.009 CID_124202060 | CID_124202060 | |
| 0.155 | 0.074 | 0.155 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.093 | 0.012 | 0.093 | Beta 1 adrenoreceptor antagonist | |||
| 0.105 | 0.024 | 0.105 | Thioredoxin reductase inhibitor | |||
| 0.139 | 0.058 | 0.139 | MAP kinase kinase inhibitor | |||
| 0.088 | 0.007 | 0.245 | Mannosidase inhibitor | 0.089 0.007 CID_22473 0.245 0.003 CID_124202060 0.123 0.004 CID_3083879 | CID_124202060 | |
| 0.084 | 0.004 | 0.084 | Glutamate (mGluR8) agonist | 0.036 0.031 CID_3083879 | ||
| 0.166 | 0.085 | 0.166 | Lipocortins synthesis antagonist | 0.135 0.13 CID_124202060 | ||
| 0.104 | 0.025 | 0.104 | Caspase 7 inhibitor | |||
| 0.096 | 0.017 | 0.096 | Ornithine carbamoyltransferase inhibitor | 0.05 0.04 CID_124202060 0.048 0.041 CID_3083879 | ||
| 0.082 | 0.004 | 0.082 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.103 | 0.026 | 0.117 | Interferon agonist | 0.077 0.057 CID_22473 0.117 0.018 CID_124202060 0.09 0.038 CID_3083879 | CID_124202060 | |
| 0.084 | 0.007 | 0.084 | Beta 2 adrenoreceptor agonist | 0.064 0.034 CID_3083879 | ||
| 0.094 | 0.018 | 0.139 | Neuraminidase inhibitor | 0.075 0.029 CID_22473 0.139 0.007 CID_124202060 0.129 0.008 CID_3083879 | CID_124202060 | |
| 0.141 | 0.065 | 0.141 | Interleukin 1 antagonist | |||
| 0.094 | 0.018 | 0.097 | NMDA 2C receptor antagonist | 0.064 0.04 CID_22473 0.097 0.017 CID_3083879 | CID_3083879 | |
| 0.088 | 0.012 | 0.088 | Glucosylceramidase inhibitor | 0.05 0.049 CID_124202060 | ||
| 0.085 | 0.01 | 0.085 | Beta 2 adrenoreceptor antagonist | |||
| 0.105 | 0.031 | 0.105 | Opioid kappa receptor antagonist | |||
| 0.085 | 0.011 | 0.085 | Calcium channel P-type blocker | 0.065 0.039 CID_22473 | ||
| 0.092 | 0.019 | 0.092 | 5 Hydroxytryptamine 3 agonist | |||
| 0.101 | 0.028 | 0.101 | Alpha adrenoreceptor agonist | |||
| 0.214 | 0.142 | 0.214 | Thyroid hormone beta antagonist | |||
| 0.183 | 0.111 | 0.183 | ErbB-1 antagonist | |||
| 0.114 | 0.042 | 0.114 | Nitric-oxide synthase inhibitor | |||
| 0.094 | 0.023 | 0.094 | Aromatase inhibitor | 0.069 0.035 CID_3083879 | ||
| 0.085 | 0.015 | 0.085 | MDM2 inhibitor | |||
| 0.076 | 0.005 | 0.076 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.12 | 0.05 | 0.12 | Alpha 2c adrenoreceptor antagonist | |||
| 0.084 | 0.015 | 0.084 | Botulinum neurotoxin type A inhibitor | |||
| 0.14 | 0.07 | 0.14 | Toll-Like receptor 9 antagonist | |||
| 0.153 | 0.083 | 0.153 | Sigma receptor agonist | |||
| 0.11 | 0.041 | 0.11 | Opioid antagonist | |||
| 0.081 | 0.011 | 0.081 | NMDA receptor subunit 3A antagonist | |||
| 0.104 | 0.035 | 0.104 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.09 | 0.021 | 0.09 | Potassium channel (ATP-sensitive) blocker | |||
| 0.099 | 0.03 | 0.099 | Opioid delta receptor antagonist | |||
| 0.075 | 0.006 | 0.075 | GABA uptake inhibitor | |||
| 0.158 | 0.09 | 0.158 | LIM domain kinase 1 inhibitor | |||
| 0.088 | 0.02 | 0.088 | Aryl hydrocarbon receptor antagonist | |||
| 0.082 | 0.014 | 0.082 | Heme oxygenase stimulant | |||
| 0.083 | 0.015 | 0.083 | Cyclin D1 inhibitor | |||
| 0.072 | 0.004 | 0.072 | Estrogen-related receptor beta antagonist | |||
| 0.077 | 0.009 | 0.082 | Phosphoglycerate kinase inhibitor | 0.08 0.008 CID_22473 0.033 0.027 CID_124202060 0.082 0.008 CID_3083879 | CID_3083879 | |
| 0.097 | 0.029 | 0.499 | Selectin antagonist | 0.296 0.005 CID_22473 0.499 0.003 CID_124202060 0.359 0.004 CID_3083879 | CID_124202060 | |
| 0.075 | 0.008 | 0.075 | Purinergic P2X4 antagonist | |||
| 0.117 | 0.05 | 0.117 | Electron transport complex I inhibitor | |||
| 0.071 | 0.004 | 0.071 | Kainate receptor agonist | |||
| 0.071 | 0.005 | 0.072 | Guanylate cyclase inhibitor | 0.072 0.004 CID_22473 0.072 0.004 CID_124202060 0.07 0.005 CID_3083879 | CID_124202060 | |
| 0.073 | 0.006 | 0.073 | Geranyltranstransferase inhibitor | |||
| 0.079 | 0.013 | 0.079 | Carbonic anhydrase VII inhibitor | 0.053 0.025 CID_124202060 | ||
| 0.074 | 0.009 | 0.074 | Immunoglobulin Fc receptor antagonist | |||
| 0.091 | 0.026 | 0.091 | Acetylcholine M5 receptor agonist | |||
| 0.078 | 0.013 | 0.078 | Bcl-xL inhibitor | |||
| 0.087 | 0.023 | 0.087 | Carbonic anhydrase stimulant | |||
| 0.07 | 0.005 | 0.07 | Nerve growth factor antagonist | |||
| 0.085 | 0.02 | 0.095 | Interferon inducer | 0.064 0.045 CID_22473 0.095 0.014 CID_124202060 0.076 0.027 CID_3083879 | CID_124202060 | |
| 0.101 | 0.036 | 0.101 | Alpha 2a adrenoreceptor antagonist | |||
| 0.078 | 0.013 | 0.078 | Glutamate (mGluR group III) agonist | |||
| 0.147 | 0.082 | 0.147 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.12 | 0.056 | 0.12 | GABA receptor agonist | |||
| 0.083 | 0.019 | 0.083 | NMDA 2A receptor antagonist | 0.054 0.034 CID_3083879 | ||
| 0.074 | 0.01 | 0.074 | Dihydroorotase inhibitor | |||
| 0.097 | 0.034 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.083 | 0.02 | 0.623 | NMDA 2B receptor antagonist | 0.477 0.003 CID_22473 0.623 0.003 CID_3083879 | CID_3083879 | |
| 0.125 | 0.062 | 0.125 | Acetylcholine muscarinic antagonist | |||
| 0.07 | 0.008 | 0.07 | Dihydropteroate synthase inhibitor | 0.036 0.033 CID_22473 0.036 0.033 CID_3083879 | ||
| 0.066 | 0.005 | 0.066 | ATP citrate lysase inhibitor | |||
| 0.101 | 0.039 | 0.101 | Bromodomain-containing protein 2 inhibitor | |||
| 0.066 | 0.005 | 0.066 | Uridine phosphorylase inhibitor | 0.058 0.006 CID_124202060 0.026 0.021 CID_3083879 | ||
| 0.272 | 0.211 | 0.272 | MAP kinase 1 inhibitor | |||
| 0.104 | 0.044 | 0.104 | Potassium channel activator | |||
| 0.073 | 0.013 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.072 | 0.012 | 0.072 | Leukotriene C antagonist | |||
| 0.09 | 0.03 | 0.09 | Amidase inhibitor | |||
| 0.129 | 0.071 | 0.129 | Cyclooxygenase 2 inhibitor | 0.105 0.099 CID_22473 0.114 0.087 CID_3083879 | ||
| 0.073 | 0.014 | 0.073 | Potassium channel Kv1.3 blocker | |||
| 0.062 | 0.004 | 0.062 | CF transmembrane conductance regulator antagonist | |||
| 0.088 | 0.03 | 0.103 | Phosphodiesterase VI inhibitor | 0.103 0.018 CID_124202060 | CID_124202060 | |
| 0.078 | 0.021 | 0.078 | Phosphodiesterase 1C inhibitor | |||
| 0.068 | 0.011 | 0.068 | Cholesterol esterase inhibitor | |||
| 0.092 | 0.035 | 0.092 | Opioid mu receptor antagonist | |||
| 0.072 | 0.016 | 0.072 | Epithelial sodium channel blocker | |||
| 0.063 | 0.007 | 0.063 | Glutamate (mGluR3) antagonist | |||
| 0.085 | 0.029 | 0.085 | Leukotriene antagonist | 0.074 0.036 CID_124202060 0.064 0.046 CID_3083879 | ||
| 0.066 | 0.01 | 0.066 | Liver X receptor alpha agonist | |||
| 0.06 | 0.005 | 0.06 | Protein kinase (CK2) beta inhibitor | |||
| 0.113 | 0.058 | 0.338 | Multidrug resistance-associated protein 1 inhibitor | 0.338 0.003 CID_22473 0.144 0.028 CID_124202060 0.334 0.003 CID_3083879 | CID_22473 | |
| 0.081 | 0.026 | 0.081 | 5 Hydroxytryptamine 2A agonist | |||
| 0.097 | 0.042 | 0.234 | Transcription factor NF kappa B stimulant | 0.234 0.007 CID_124202060 | CID_124202060 | |
| 0.075 | 0.021 | 0.075 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.164 | 0.109 | 0.164 | Focal adhesion kinase 2 inhibitor | |||
| 0.059 | 0.005 | 0.059 | Vanilloid 3 antagonist | |||
| 0.071 | 0.017 | 0.071 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.071 | 0.017 | 0.071 | Lysine-specific demethylase 1A inhibitor | |||
| 0.101 | 0.047 | 0.101 | Alpha 2 adrenoreceptor antagonist | |||
| 0.068 | 0.014 | 0.068 | Adenosine deaminase inhibitor | 0.06 0.021 CID_124202060 0.057 0.024 CID_3083879 | ||
| 0.132 | 0.078 | 0.132 | Cytokine production inhibitor | |||
| 0.062 | 0.008 | 0.062 | Sphingosine kinase 1 inhibitor | |||
| 0.063 | 0.01 | 0.063 | Nicotinic acid receptor agonist | |||
| 0.056 | 0.003 | 0.056 | Estrogen-related receptor gamma antagonist | 0.031 0.013 CID_3083879 | ||
| 0.057 | 0.004 | 0.057 | Alpha 2a adrenoreceptor agonist | |||
| 0.127 | 0.075 | 0.133 | Nav1.2 sodium channel blocker | 0.133 0.069 CID_22473 0.112 0.093 CID_3083879 | CID_22473 | |
| 0.114 | 0.062 | 0.114 | Nav1.5 sodium channel blocker | |||
| 0.064 | 0.013 | 0.064 | Oxytocin agonist | |||
| 0.07 | 0.019 | 0.114 | Leukotriene B4 antagonist | 0.067 0.022 CID_22473 0.114 0.008 CID_124202060 0.078 0.016 CID_3083879 | CID_124202060 | |
| 0.062 | 0.011 | 0.062 | GABA B receptor antagonist | |||
| 0.079 | 0.028 | 0.079 | Protease 3C (Human rhinovirus) inhibitor | 0.073 0.033 CID_22473 0.076 0.03 CID_3083879 | ||
| 0.063 | 0.013 | 0.063 | Glutamate (mGluR4) antagonist | |||
| 0.06 | 0.01 | 0.101 | Arginase inhibitor | 0.101 0.004 CID_124202060 | CID_124202060 | |
| 0.076 | 0.026 | 0.076 | Protein kinase C eta inhibitor | |||
| 0.055 | 0.005 | 0.128 | Glutamate (mGluR1a) agonist | 0.073 0.004 CID_22473 0.128 0.003 CID_3083879 | CID_3083879 | |
| 0.062 | 0.012 | 0.062 | Glutamate (mGluR group III) antagonist | |||
| 0.075 | 0.025 | 0.078 | Transcription factor AP-1 inhibitor | 0.078 0.023 CID_124202060 | CID_124202060 | |
| 0.124 | 0.074 | 0.124 | Acetylcholinesterase inhibitor | |||
| 0.098 | 0.049 | 0.098 | Calcium antagonist | |||
| 0.13 | 0.08 | 0.13 | Histone deacetylase SIRT1 inhibitor | |||
| 0.097 | 0.048 | 0.097 | Phosphodiesterase I inhibitor | |||
| 0.054 | 0.004 | 0.054 | Glutamate (mGluR3) agonist | 0.031 0.026 CID_124202060 | ||
| 0.056 | 0.007 | 0.056 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.073 | 0.024 | 0.073 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.057 | 0.008 | 0.057 | Heme oxygenase inhibitor | |||
| 0.058 | 0.009 | 0.058 | Beta adrenoreceptor agonist | |||
| 0.087 | 0.039 | 0.087 | Metalloproteinase-9 inhibitor | |||
| 0.081 | 0.035 | 0.081 | Elastase 1 inhibitor | |||
| 0.062 | 0.016 | 0.071 | Factor III inhibitor | 0.071 0.01 CID_124202060 | CID_124202060 | |
| 0.08 | 0.034 | 0.08 | Potassium channel (Tandem pore domain) blocker | |||
| 0.081 | 0.035 | 0.081 | Secretase beta inhibitor | |||
| 0.074 | 0.029 | 0.074 | Ribonucleotide reductase inhibitor | |||
| 0.094 | 0.049 | 0.335 | Antineoplastic antibiotic | 0.335 0.008 CID_124202060 0.091 0.05 CID_3083879 | CID_124202060 | |
| 0.066 | 0.021 | 0.066 | DNA helicase inhibitor | |||
| 0.068 | 0.023 | 0.068 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.084 | 0.039 | 0.086 | HIV-1 reverse transcriptase inhibitor | 0.086 0.038 CID_3083879 | CID_3083879 | |
| 0.061 | 0.017 | 0.061 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.072 | 0.028 | 0.072 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.079 | 0.035 | 0.244 | Carbonic anhydrase inhibitor | 0.195 0.01 CID_22473 0.073 0.038 CID_124202060 0.244 0.006 CID_3083879 | CID_3083879 | |
| 0.063 | 0.019 | 0.207 | Heparanase inhibitor | 0.101 0.004 CID_22473 0.207 0.002 CID_124202060 0.091 0.004 CID_3083879 | CID_124202060 | |
| 0.062 | 0.018 | 0.062 | Potassium channel (Inward rectifier) activator | |||
| 0.058 | 0.015 | 0.058 | Urate transporter 1 inhibitor | |||
| 0.058 | 0.015 | 0.058 | AICAR transformylase inhibitor | 0.042 0.034 CID_3083879 | ||
| 0.081 | 0.038 | 0.081 | Cyclin B3 inhibitor | |||
| 0.046 | 0.005 | 0.063 | Thyroid hormone agonist | 0.03 0.012 CID_22473 0.063 0.004 CID_3083879 | CID_3083879 | |
| 0.063 | 0.021 | 0.063 | Prolyl endopeptidase inhibitor | |||
| 0.057 | 0.016 | 0.063 | Cytokine production stimulant | 0.063 0.01 CID_124202060 | CID_124202060 | |
| 0.058 | 0.018 | 0.058 | Potassium channel (ATP-sensitive) activator | |||
| 0.05 | 0.009 | 0.05 | Free fatty acid receptor 1 antagonist | |||
| 0.08 | 0.039 | 0.08 | Prostaglandin-E synthase inhibitor | |||
| 0.047 | 0.007 | 0.128 | Sodium/glucose cotransporter 2 inhibitor | 0.128 0.002 CID_124202060 | CID_124202060 | |
| 0.053 | 0.013 | 0.053 | Retinoid X alpha receptor agonist | |||
| 0.065 | 0.025 | 0.065 | 5 Hydroxytryptamine 7 agonist | |||
| 0.049 | 0.009 | 0.049 | Liver X receptor beta antagonist | |||
| 0.043 | 0.004 | 0.067 | Vanilloid 2 agonist | 0.027 0.014 CID_22473 0.067 0.002 CID_124202060 0.04 0.004 CID_3083879 | CID_124202060 | |
| 0.055 | 0.016 | 0.055 | Thymidine kinase inhibitor | 0.045 0.023 CID_3083879 | ||
| 0.081 | 0.042 | 0.081 | Adenosine A3 receptor antagonist | |||
| 0.055 | 0.016 | 0.055 | Retinoid X receptor agonist | |||
| 0.051 | 0.012 | 0.051 | Retinoid X receptor antagonist | |||
| 0.086 | 0.047 | 0.086 | Metalloproteinase-2 inhibitor | |||
| 0.043 | 0.005 | 0.043 | Purinergic P2Y15 antagonist | |||
| 0.069 | 0.03 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.07 | 0.033 | 0.07 | TRPA1 antagonist | |||
| 0.065 | 0.028 | 0.078 | Lipocortins synthesis agonist | 0.078 0.014 CID_124202060 | CID_124202060 | |
| 0.067 | 0.03 | 0.131 | Carbonic anhydrase XII inhibitor | 0.074 0.028 CID_22473 0.131 0.015 CID_124202060 0.118 0.017 CID_3083879 | CID_124202060 | |
| 0.046 | 0.01 | 0.046 | Ceramide glucosyltransferase inhibitor | 0.032 0.031 CID_22473 0.034 0.028 CID_124202060 0.042 0.015 CID_3083879 | ||
| 0.042 | 0.005 | 0.042 | Prostaglandin F2 alpha agonist | |||
| 0.043 | 0.007 | 0.043 | CXC chemokine 2 receptor antagonist | |||
| 0.105 | 0.069 | 0.195 | DNA intercalator | 0.195 0.027 CID_124202060 | CID_124202060 | |
| 0.041 | 0.004 | 0.041 | Hedgehog signaling activator | |||
| 0.12 | 0.084 | 0.12 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.061 | 0.026 | 0.061 | Thromboxane synthase inhibitor | |||
| 0.125 | 0.09 | 0.125 | Activin receptor-like kinase 2 inhibitor | |||
| 0.049 | 0.013 | 0.049 | Sirtuin 2 inhibitor | |||
| 0.039 | 0.003 | 0.039 | Nicotinic acid receptor 1 antagonist | |||
| 0.039 | 0.005 | 0.039 | Nicotinic acid receptor 2 antagonist | |||
| 0.072 | 0.038 | 0.072 | Neutrophil collagenase inhibitor | |||
| 0.047 | 0.013 | 0.047 | Delayed rectifier potassium channel blocker | |||
| 0.047 | 0.013 | 0.047 | Leukotriene C4 antagonist | |||
| 0.044 | 0.01 | 0.044 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.045 | 0.011 | 0.045 | Tubulin agonist | |||
| 0.067 | 0.033 | 0.067 | Acetylcholine M5 receptor antagonist | |||
| 0.055 | 0.022 | 0.055 | Thymidylate synthase inhibitor | |||
| 0.036 | 0.003 | 0.036 | Estrogen-related receptor gamma agonist | |||
| 0.055 | 0.022 | 0.055 | Carbonic anhydrase IV inhibitor | |||
| 0.065 | 0.033 | 0.065 | Prolactin release inhibitor | |||
| 0.049 | 0.016 | 0.049 | AMPA 4 receptor antagonist | |||
| 0.113 | 0.081 | 0.113 | Cholinergic antagonist | |||
| 0.075 | 0.043 | 0.075 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.093 | 0.061 | 0.093 | ABCA1 expression enhancer | |||
| 0.079 | 0.047 | 0.079 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.039 | 0.007 | 0.136 | Sodium/glucose cotransporter inhibitor | 0.136 0.002 CID_124202060 | CID_124202060 | |
| 0.08 | 0.048 | 0.08 | Analgesic, opioid | |||
| 0.057 | 0.026 | 0.138 | Phosphorylase inhibitor | 0.138 0.008 CID_124202060 | CID_124202060 | |
| 0.063 | 0.033 | 0.111 | Carbonic anhydrase II inhibitor | 0.08 0.025 CID_22473 0.05 0.045 CID_124202060 0.111 0.016 CID_3083879 | CID_3083879 | |
| 0.065 | 0.035 | 0.065 | Acetylcholine M3 receptor antagonist | |||
| 0.042 | 0.012 | 0.042 | Retinoid X alpha receptor antagonist | |||
| 0.072 | 0.042 | 0.072 | Sirtuin 1 inhibitor | |||
| 0.039 | 0.009 | 0.039 | Liver X receptor alpha antagonist | |||
| 0.047 | 0.017 | 0.047 | Diamine oxidase inhibitor | |||
| 0.065 | 0.035 | 0.098 | Carbonic anhydrase IX inhibitor | 0.076 0.029 CID_22473 0.079 0.027 CID_124202060 0.098 0.02 CID_3083879 | CID_3083879 | |
| 0.059 | 0.029 | 0.059 | Thromboxane A2 antagonist | |||
| 0.046 | 0.017 | 0.046 | Farnesoid X receptor agonist | 0.036 0.029 CID_22473 0.043 0.02 CID_3083879 | ||
| 0.047 | 0.018 | 0.047 | Membrane dipeptidase inhibitor | |||
| 0.061 | 0.032 | 0.061 | Thromboxane antagonist | |||
| 0.109 | 0.081 | 0.109 | Acetylcholine antagonist | |||
| 0.04 | 0.012 | 0.04 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.031 | 0.003 | 0.051 | Antibiotic Anthracycline-like | 0.051 0.002 CID_124202060 | CID_124202060 | |
| 0.149 | 0.121 | 0.149 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.157 | 0.13 | 0.371 | Hypolipemic | 0.371 0.031 CID_124202060 | CID_124202060 | |
| 0.062 | 0.035 | 0.062 | Alpha 1 adrenoreceptor agonist | |||
| 0.042 | 0.015 | 0.042 | Glutamate (mGluR4) agonist | |||
| 0.04 | 0.013 | 0.04 | Cholesterol ester transfer protein antagonist | 0.035 0.017 CID_22473 0.032 0.021 CID_3083879 | ||
| 0.038 | 0.012 | 0.038 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.065 | 0.039 | 0.065 | Prostaglandin F2 alpha antagonist | |||
| 0.048 | 0.022 | 0.048 | Histamine H1 receptor agonist | |||
| 0.079 | 0.053 | 0.079 | Somatostatin 1 agonist | |||
| 0.031 | 0.005 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.023 0.014 CID_124202060 | ||
| 0.033 | 0.008 | 0.052 | Glutamate (mGluR1) agonist | 0.028 0.012 CID_22473 0.052 0.005 CID_3083879 | CID_3083879 | |
| 0.042 | 0.017 | 0.042 | RNA-directed RNA polymerase inhibitor | |||
| 0.064 | 0.039 | 0.064 | Histone deacetylase SIRT3 inhibitor | |||
| 0.039 | 0.014 | 0.039 | Liver X receptor antagonist | |||
| 0.084 | 0.059 | 0.084 | Bcr-Abl kinase inhibitor | |||
| 0.028 | 0.003 | 0.028 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.028 | 0.003 | 0.028 | Glutamate (mGluR6) agonist | 0.012 0.009 CID_3083879 | ||
| 0.043 | 0.019 | 0.043 | Potassium channel Kv1.1 blocker | |||
| 0.031 | 0.007 | 0.031 | Complement factor 1s inhibitor | |||
| 0.155 | 0.131 | 0.155 | Growth factor agonist | |||
| 0.028 | 0.004 | 0.037 | Telomerase stimulant | 0.037 0.002 CID_124202060 | CID_124202060 | |
| 0.033 | 0.01 | 0.033 | Prostaglandin H2 antagonist | |||
| 0.083 | 0.059 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.062 | 0.039 | 0.062 | Phosphodiesterase 1B inhibitor | |||
| 0.028 | 0.005 | 0.028 | Thyroid hormone alpha antagonist | |||
| 0.033 | 0.01 | 0.033 | Thymidine phosphorylase inhibitor | |||
| 0.032 | 0.009 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.017 CID_3083879 | ||
| 0.059 | 0.036 | 0.114 | Carbonic anhydrase I inhibitor | 0.087 0.022 CID_22473 0.047 0.045 CID_124202060 0.114 0.015 CID_3083879 | CID_3083879 | |
| 0.109 | 0.086 | 0.109 | Nav1.3 sodium channel blocker | |||
| 0.039 | 0.016 | 0.039 | Liver X receptor beta agonist | |||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.036 | 0.014 | 0.036 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 CID_124202060 | ||
| 0.051 | 0.028 | 0.051 | Aldosterone antagonist | |||
| 0.063 | 0.041 | 0.063 | I kappa B kinase 2 inhibitor | |||
| 0.043 | 0.022 | 0.043 | 5-Alpha-reductase inhibitor | |||
| 0.046 | 0.025 | 0.046 | Histamine H2 receptor agonist | |||
| 0.062 | 0.041 | 0.062 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.041 | 0.02 | 0.041 | Integrin alpha2 antagonist | |||
| 0.041 | 0.021 | 0.041 | Kainate receptor 2 antagonist | |||
| 0.034 | 0.013 | 0.034 | Lysine carboxypeptidase inhibitor | |||
| 0.026 | 0.006 | 0.064 | Ileal bile acid transport inhibitor | 0.064 0.003 CID_124202060 | CID_124202060 | |
| 0.025 | 0.005 | 0.025 | Alpha 2b adrenoreceptor agonist | |||
| 0.029 | 0.009 | 0.029 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.042 | 0.022 | 0.042 | TRPM8 blocker | |||
| 0.051 | 0.032 | 0.051 | Bombesin 2 receptor antagonist | |||
| 0.024 | 0.005 | 0.024 | NMDA receptor phencyclidine site antagonist | |||
| 0.06 | 0.041 | 0.06 | Phosphodiesterase 1A inhibitor | |||
| 0.036 | 0.017 | 0.036 | HCV NS5B polymerase inhibitor | |||
| 0.084 | 0.065 | 0.091 | Interleukin 5 antagonist | 0.091 0.053 CID_124202060 | CID_124202060 | |
| 0.08 | 0.061 | 0.08 | I kappa B kinase inhibitor | |||
| 0.028 | 0.009 | 0.028 | Beta 1 adrenoreceptor agonist | |||
| 0.077 | 0.058 | 0.077 | Acetylcholine nicotinic antagonist | |||
| 0.06 | 0.041 | 0.06 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.03 | 0.011 | 0.03 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.026 | 0.007 | 0.026 | Neuraminidase (Influenza B) inhibitor | |||
| 0.041 | 0.023 | 0.041 | 5 Hydroxytryptamine 2B agonist | |||
| 0.085 | 0.067 | 0.085 | Antiadrenergic | |||
| 0.023 | 0.005 | 0.023 | Thyroid hormone alpha agonist | |||
| 0.044 | 0.026 | 0.044 | Histone deacetylase 8 inhibitor | |||
| 0.031 | 0.014 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.036 | 0.018 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.032 | 0.015 | 0.032 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.022 | 0.005 | 0.022 | Thromboxane A2 agonist | |||
| 0.037 | 0.02 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.056 | 0.038 | 0.056 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.046 | 0.03 | 0.073 | Neuraminidase (Influenza A) inhibitor | 0.073 0.006 CID_124202060 | CID_124202060 | |
| 0.044 | 0.028 | 0.073 | Dihydrofolate reductase inhibitor | 0.073 0.005 CID_22473 0.049 0.02 CID_3083879 | CID_22473 | |
| 0.065 | 0.049 | 0.065 | Neuronal nicotinic receptor antagonist | |||
| 0.034 | 0.018 | 0.034 | Prostaglandin agonist | |||
| 0.048 | 0.032 | 0.048 | Glycine transporter 2 inhibitor | |||
| 0.026 | 0.01 | 0.026 | ICAM 1 antagonist | |||
| 0.046 | 0.03 | 0.046 | Purinergic P2Y antagonist | |||
| 0.017 | 0.002 | 0.017 | Insulin like growth factor 3 antagonist | |||
| 0.039 | 0.023 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.064 | 0.049 | 0.064 | Matrix metalloproteinase inhibitor | |||
| 0.047 | 0.032 | 0.047 | CC chemokine 4 receptor antagonist | |||
| 0.034 | 0.019 | 0.034 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.086 | 0.07 | 0.086 | Polo-like kinase-1 inhibitor | |||
| 0.026 | 0.011 | 0.028 | Leukotriene B4 receptor 2 antagonist | 0.028 0.01 CID_124202060 | CID_124202060 | |
| 0.084 | 0.069 | 0.084 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.052 | 0.037 | 0.052 | Matrix metalloproteinase 1 inhibitor | |||
| 0.029 | 0.014 | 0.029 | Integrin alpha2beta1 antagonist | |||
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.024 | 0.009 | 0.024 | Retinoid X beta receptor antagonist | |||
| 0.082 | 0.067 | 0.082 | Adrenaline antagonist | |||
| 0.021 | 0.007 | 0.021 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.03 | 0.015 | 0.068 | Kynurenine 3 monooxygenase inhibitor | 0.068 0.005 CID_22473 0.043 0.008 CID_3083879 | CID_22473 | |
| 0.038 | 0.024 | 0.038 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.042 | 0.028 | 0.042 | CDK5/p25 inhibitor | |||
| 0.046 | 0.032 | 0.046 | Opioid mu receptor agonist | |||
| 0.032 | 0.019 | 0.032 | AMPA 3 receptor antagonist | |||
| 0.05 | 0.036 | 0.05 | Alpha 1b adrenoreceptor agonist | |||
| 0.048 | 0.035 | 0.048 | HCV NS3/NS4A protease inhibitor | |||
| 0.02 | 0.007 | 0.02 | Purinergic P2Y1 agonist | 0.019 0.008 CID_3083879 | ||
| 0.021 | 0.008 | 0.021 | Carbonic anhydrase X inhibitor | |||
| 0.021 | 0.008 | 0.021 | Carbonic anhydrase VIII inhibitor | |||
| 0.049 | 0.036 | 0.049 | Potassium channel (Inward rectifier) blocker | |||
| 0.027 | 0.014 | 0.027 | NMDA receptor glycine site antagonist | |||
| 0.039 | 0.027 | 0.039 | MAP3K5 inhibitor | |||
| 0.027 | 0.015 | 0.027 | Dopamine autoreceptor agonist | |||
| 0.056 | 0.044 | 0.056 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.017 | 0.006 | 0.017 | Antibiotic Tetracycline-like | |||
| 0.095 | 0.084 | 0.191 | Nav1.4 sodium channel blocker | 0.154 0.032 CID_22473 0.191 0.021 CID_3083879 | CID_3083879 | |
| 0.046 | 0.035 | 0.046 | Antimetabolite | |||
| 0.046 | 0.035 | 0.046 | AMPA receptor antagonist | |||
| 0.021 | 0.01 | 0.021 | Alpha 2c adrenoreceptor agonist | |||
| 0.026 | 0.016 | 0.026 | Acid ceramidase inhibitor | |||
| 0.04 | 0.029 | 0.04 | Toll-Like receptor 2 agonist | |||
| 0.04 | 0.029 | 0.04 | Kainate receptor antagonist | |||
| 0.143 | 0.133 | 0.143 | Death-associated protein kinase 3 inhibitor | |||
| 0.025 | 0.015 | 0.025 | Prostaglandin EP2 agonist | |||
| 0.038 | 0.028 | 0.038 | Histone deacetylase 9 inhibitor | |||
| 0.026 | 0.016 | 0.026 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.017 | 0.007 | 0.017 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.015 | 0.005 | 0.015 | Egl nine homolog 3 inhibitor | |||
| 0.046 | 0.036 | 0.046 | Benzodiazepine antagonist | |||
| 0.054 | 0.045 | 0.054 | Adenosine A1 receptor antagonist | |||
| 0.017 | 0.008 | 0.017 | Egl nine homolog 1 inhibitor | |||
| 0.04 | 0.032 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.028 | 0.019 | 0.028 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.051 | 0.043 | 0.051 | GABA receptor antagonist | |||
| 0.034 | 0.026 | 0.034 | Progesterone antagonist | |||
| 0.012 | 0.004 | 0.012 | Thyroid hormone beta agonist | |||
| 0.013 | 0.005 | 0.013 | Thromboxane agonist | |||
| 0.019 | 0.012 | 0.019 | Cyclin T1 inhibitor | |||
| 0.032 | 0.025 | 0.032 | Calcitonin receptor agonist | |||
| 0.012 | 0.005 | 0.012 | Progesterone receptor A antagonist | |||
| 0.04 | 0.033 | 0.04 | Angiotensin AT1 receptor antagonist | |||
| 0.01 | 0.004 | 0.01 | DNA topoisomerase III inhibitor | |||
| 0.05 | 0.044 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.028 | 0.021 | 0.028 | CDK4/cyclin D3 inhibitor | |||
| 0.034 | 0.027 | 0.035 | Adenosine uptake inhibitor | 0.035 0.025 CID_22473 | CID_22473 | |
| 0.051 | 0.045 | 0.051 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.029 | 0.023 | 0.029 | Peptide deformylase inhibitor | |||
| 0.042 | 0.035 | 0.042 | Oleamide hydrolase inhibitor | |||
| 0.023 | 0.017 | 0.023 | Prostaglandin E2 agonist | |||
| 0.04 | 0.034 | 0.254 | Leukocyte elastase inhibitor | 0.254 0.004 CID_22473 0.228 0.004 CID_3083879 | CID_22473 | |
| 0.018 | 0.013 | 0.018 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.027 | 0.021 | 0.027 | LFA antagonist | |||
| 0.027 | 0.022 | 0.113 | 1,3-Beta-glucan synthase inhibitor | 0.075 0.002 CID_22473 0.035 0.007 CID_124202060 0.113 0.001 CID_3083879 | CID_3083879 | |
| 0.026 | 0.021 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.032 | 0.027 | 0.032 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.027 | 0.023 | 0.027 | Glucagon receptor antagonist | |||
| 0.019 | 0.015 | 0.019 | Caspase 8 inhibitor | |||
| 0.019 | 0.014 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.016 | 0.012 | 0.016 | Adenosine A2 receptor agonist | |||
| 0.034 | 0.03 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.031 | 0.027 | 0.031 | Vanilloid 4 antagonist | |||
| 0.086 | 0.082 | 0.086 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.03 | 0.026 | 0.03 | Estrogen-related receptor alpha antagonist | |||
| 0.076 | 0.072 | 0.076 | GABA A receptor agonist | |||
| 0.033 | 0.03 | 0.033 | Histone deacetylase 7 inhibitor | |||
| 0.036 | 0.032 | 0.036 | Dopamine D3 agonist | |||
| 0.015 | 0.011 | 0.015 | Adenosine A2a receptor agonist | |||
| 0.04 | 0.037 | 0.04 | Sphingosine 1-phosphate receptor agonist | |||
| 0.031 | 0.028 | 0.031 | Carnitine palmitoyltransferase inhibitor | |||
| 0.011 | 0.008 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.051 | 0.048 | 0.051 | Dopamine uptake inhibitor | |||
| 0.064 | 0.061 | 0.064 | Calcium channel L-type blocker | |||
| 0.013 | 0.01 | 0.013 | Cyclin D2 inhibitor | |||
| 0.01 | 0.008 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 CID_124202060 | CID_124202060 | |
| 0.032 | 0.029 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.03 CID_124202060 | ||
| 0.018 | 0.015 | 0.018 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.038 | 0.036 | 0.038 | Plasmepsin II inhibitor | |||
| 0.045 | 0.043 | 0.045 | 5 Hydroxytryptamine 2 agonist | |||
| 0.006 | 0.004 | 0.006 | Transcortin receptor antagonist | |||
| 0.015 | 0.014 | 0.015 | Vitamin D receptor agonist | |||
| 0.144 | 0.143 | 0.144 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.02 | 0.019 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | |||
| 0.032 | 0.031 | 0.032 | Opioid delta receptor agonist | |||
| 0.028 | 0.027 | 0.028 | Epoxide hydrolase 1 inhibitor | |||
| 0.014 | 0.013 | 0.014 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.034 | 0.033 | 0.034 | Cathepsin L2 inhibitor | |||
| 0.017 | 0.021 | 0.182 | Estrone sulfatase inhibitor | 0.164 0.003 CID_22473 0.182 0.002 CID_3083879 | CID_3083879 | |
| 0.02 | 0.024 | 0.086 | Protein 30S ribosomal subunit inhibitor | 0.086 0.004 CID_124202060 | CID_124202060 | |
| 0.039 | 0.048 | 0.046 | Metalloproteinase-3 inhibitor | 0.046 0.038 CID_22473 | CID_22473 | |
| 0.01 | 0.029 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.011 CID_124202060 | CID_124202060 | |
| 0.019 | 0.039 | 0.251 | NMDA 2D receptor antagonist | 0.208 0.003 CID_22473 0.251 0.002 CID_3083879 | CID_3083879 | |
| 0.07 | 0.09 | 0.124 | Falcipain inhibitor | 0.124 0.042 CID_124202060 | CID_124202060 | |
| 0.068 | 0.088 | 0.122 | Falcipain 2 inhibitor | 0.122 0.041 CID_124202060 | CID_124202060 | |
| 0.013 | 0.036 | 0.023 | Corticosteroid-like | 0.023 0.012 CID_124202060 | CID_124202060 | |
| 0.04 | 0.065 | 0.054 | Prostaglandin EP2 antagonist | 0.054 0.047 CID_124202060 | CID_124202060 | |
| 0.042 | 0.07 | 0.095 | Purinergic P2X2 antagonist | 0.095 0.033 CID_22473 | CID_22473 | |
| 0.026 | 0.062 | 0.101 | Antibiotic Aminoglycoside-like | 0.101 0.003 CID_124202060 | CID_124202060 | |
| 0.004 | 0.043 | 0.013 | Purinergic P2 agonist | 0.013 0.012 CID_124202060 | CID_124202060 | |
| 0.004 | 0.043 | 0.013 | Purinergic receptor agonist | 0.013 0.012 CID_124202060 | CID_124202060 | |
| 0.032 | 0.073 | 0.161 | Protein 50S ribosomal subunit inhibitor | 0.161 0.006 CID_124202060 | CID_124202060 | |
| 0.031 | 0.073 | 0.057 | Microtubule stabilization | 0.057 0.018 CID_124202060 | CID_124202060 | |
| 0.043 | 0.085 | 0.095 | Fibroblast growth factor 2 antagonist | 0.095 0.026 CID_22473 | CID_22473 | |
| 0.127 | 0.174 | 0.428 | Platelet antagonist | 0.428 0.022 CID_124202060 0.193 0.106 CID_3083879 | CID_124202060 | |
| 0.021 | 0.071 | 0.156 | Factor Xa inhibitor | 0.122 0.01 CID_22473 0.048 0.031 CID_124202060 0.156 0.008 CID_3083879 | CID_3083879 | |
| 0.021 | 0.078 | 0.068 | Purinergic P2Y2 antagonist | 0.059 0.008 CID_22473 0.068 0.006 CID_3083879 | CID_3083879 | |
| 0.002 | 0.062 | 0.02 | Antibiotic Macrolide-like | 0.02 0.007 CID_124202060 | CID_124202060 | |
| 0.009 | 0.07 | 0.052 | Squalene synthetase inhibitor | 0.052 0.014 CID_124202060 | CID_124202060 | |
| 0.037 | 0.101 | 0.091 | Nitric oxide donor | 0.091 0.014 CID_124202060 | CID_124202060 | |
| 0.032 | 0.098 | 0.152 | Factor IXa inhibitor | 0.134 0.005 CID_22473 0.117 0.006 CID_124202060 0.152 0.004 CID_3083879 | CID_3083879 | |
| 0.068 | 0.138 | 0.098 | T cell inhibitor | 0.098 0.026 CID_124202060 | CID_124202060 | |
| 0.019 | 0.118 | 0.983 | Cholecystokinin B agonist | 0.977 0.001 CID_22473 0.983 0.001 CID_3083879 | CID_3083879 | |
| 0.026 | 0.126 | 0.097 | H+/K+-transporting ATPase inhibitor | 0.097 0.009 CID_22473 0.082 0.012 CID_3083879 | CID_22473 | |
| 0.134 | 0.263 | 0.792 | Angiogenesis inhibitor | 0.792 0.005 CID_22473 0.272 0.108 CID_124202060 0.758 0.006 CID_3083879 | CID_22473 | |
| 0.021 | 0.154 | 0.066 | Plasmin inhibitor | 0.066 0.026 CID_3083879 | CID_3083879 | |
| 0.006 | 0.145 | 0.879 | Cholecystokinin A agonist | 0.871 0.001 CID_22473 0.879 0.001 CID_3083879 | CID_3083879 | |
| 0.016 | 0.16 | 0.055 | Toll-Like receptor 4 agonist | 0.055 0.003 CID_22473 0.041 0.005 CID_124202060 0.047 0.004 CID_3083879 | CID_22473 | |
| 0.005 | 0.162 | 0.9 | Cholecystokinin agonist | 0.89 0.001 CID_22473 0.9 0.001 CID_3083879 | CID_3083879 | |
| 0.063 | 0.226 | 0.372 | Cell adhesion inhibitor | 0.372 0.006 CID_124202060 | CID_124202060 | |
| 0.102 | 0.281 | 0.37 | Beta lactamase inhibitor | 0.37 0.109 CID_22473 0.212 0.177 CID_3083879 | CID_22473 | |
| 0.01 | 0.204 | 0.02 | Follicle-stimulating hormone antagonist | 0.02 0.011 CID_22473 | CID_22473 | |
| 0.036 | 0.253 | 0.088 | Chymotrypsin inhibitor | 0.083 0.05 CID_22473 0.088 0.045 CID_3083879 | CID_3083879 | |
| 0.006 | 0.279 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.01 CID_124202060 | CID_124202060 | |
| 0.017 | 0.302 | 0.069 | DNA gyrase inhibitor | 0.069 0.037 CID_124202060 | CID_124202060 | |
| 0.012 | 0.338 | 0.211 | Elastase inhibitor | 0.193 0.004 CID_22473 0.211 0.004 CID_3083879 | CID_3083879 | |
| 0.038 | 0.366 | 0.834 | Anticoagulant | 0.721 0.005 CID_22473 0.331 0.024 CID_124202060 0.834 0.004 CID_3083879 | CID_3083879 | |
| 0.016 | 0.38 | 0.173 | Thrombin inhibitor | 0.145 0.012 CID_22473 0.173 0.008 CID_3083879 | CID_3083879 | |
| 0.022 | 0.42 | 0.163 | Cell adhesion molecule inhibitor | 0.075 0.061 CID_22473 0.163 0.013 CID_124202060 | CID_124202060 | |
| 0.072 | 0.477 | 0.326 | Toll-Like receptor 7 agonist | 0.326 0.095 CID_124202060 | CID_124202060 | |
| 0.004 | 0.416 | 0.678 | Cholecystokinin A antagonist | 0.637 0.002 CID_22473 0.678 0.002 CID_3083879 | CID_3083879 | |
| 0.067 | 0.49 | 0.353 | Toll-Like receptor agonist | 0.353 0.081 CID_124202060 | CID_124202060 | |
| 0.066 | 0.495 | 0.527 | Immunomodulator | 0.527 0.019 CID_124202060 | CID_124202060 | |
| 0.003 | 0.483 | 0.614 | Cholecystokinin B antagonist | 0.543 0.003 CID_22473 0.614 0.002 CID_3083879 | CID_3083879 | |
| 0.004 | 0.5 | 0.629 | Cholecystokinin antagonist | 0.569 0.003 CID_22473 0.629 0.003 CID_3083879 | CID_3083879 | |
| 0.046 | 0.545 | 0.372 | Antiobesity | 0.26 0.147 CID_22473 0.205 0.203 CID_124202060 0.372 0.077 CID_3083879 | CID_3083879 | |
| 0.004 | 0.529 | 0.024 | Motilin receptor agonist | 0.024 0.015 CID_124202060 | CID_124202060 | |
| 0.01 | 0.551 | 0.068 | MAP kinase kinase 10 inhibitor | 0.061 0.057 CID_22473 0.068 0.043 CID_3083879 | CID_3083879 | |
| 0.003 | 0.601 | 0.018 | Sodium/hydrogen exchanger inhibitor | 0.018 0.011 CID_22473 0.016 0.014 CID_3083879 | CID_22473 | |
| 0.004 | 0.697 | 0.092 | Factor XIa inhibitor | 0.09 0.007 CID_22473 0.092 0.006 CID_3083879 | CID_3083879 | |
| 0.003 | 0.751 | 0.109 | Factor XI inhibitor | 0.106 0.004 CID_22473 0.109 0.004 CID_3083879 | CID_3083879 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |